Scout Bio’s one-time injectable therapy for feline diabetes has the potential to provide a convenient single treatment that is an alternative to the stress of twice daily insulin injections on both owners and their cats. This initial field study will evaluate the performance of the treatment alone and in combination with insulin injections in diabetic cats.
Scout Bio is actively seeking to enroll cats that have been diagnosed with diabetes to participate in our latest FDA-regulated study. This is an opportunity to offer feline patients with diabetes a new option and to be part of a dedicated team that advances a whole new area of therapy in veterinary medicine.
We are currently offering enrollment in this study at three different university veterinary referral centers – NSCU at Raleigh,NC; University of Georgia at Athens, GA; and University of Penn at Philadelphia, PA. With your help, we can find appropriate patients to participate in this cutting-edge gene therapy study to help improve quality of life for diabetic cats. By sharing this information, you become a valuable part of the team striving to deliver clinical proof of concept for this investigational treatment.
How Can You Participate?
Newly diagnosed (<6 months on insulin) cats must be verified to have high blood glucose concentrations prior to screening and they must be exhibiting at least one of the following signs: excessive drinking, excessive urination or weight loss despite a normal or increased appetite.
Clients must commit to travel with their cat to the study site approximately every 2 weeks for an 84 day period and then once a month for 3 additional months.
Clients must be willing and able to provide accurate assessments of their cat’s well-being and progress.
Clients must be willing and able to administer insulin injections to their cat as directed by the Study Veterinarian.
Costs and Procedures Covered
There are no cost to owners for any study related exams, tests, or veterinary care
All costs of examination and any needed diagnostics and laboratory evaluations are provided at no charge by the study site for the duration of the study.
After the screening visit, if your cat is deemed eligible then they will be enrolled and at the next visit they will receive the study treatment. No cats will be given a placebo during this study.
At each visit, blood will be drawn for different evaluations, some urine will be taken at the beginning and end of the study, and on three visits your cat will be required to stay in the hospital for a 9 hour blood glucose curve evaluation.
If you live in or near one of these active study sites and are interested in enrolling your cat, please click the button and complete the questionnaire to allow us to determine if your cat may be eligible to screen.